INAB logo
INAB NASDAQ US

IN8bio, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Nov 2020
$1.44
▲ +$0.04 (+2.86%)
Vol 18K
3
Quality Score
fail
Mkt Cap
$10.8M
ROE
-145.5%
D/E
3.09
Beta
0.06
52W
$1–$13

Wall Street Consensus

10 analysts · Apr 2026
2
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating

Price Chart

Earnings

Beat rate: 75.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.63 $-0.45 +$0.18
Sep 2025 $-1.25 $-0.85 +$0.40
Jun 2025 $-1.84 $-1.24 +$0.60
Mar 2025 $-2.04 $-2.10 $-0.06

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -183.1% -183.1% -183.1% -183.1% -145.5% -145.5%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 3.48 3.48 3.48 3.48 3.09 3.09
Current Ratio 7.03 7.03 7.03 7.03 6.91 6.91

Key Ratios

ROA (TTM)
-107.4%
P/B
1.3
EPS (TTM)
$-6.48
CF/Share
$-1.05
52W High
$12.53
52W Low
$1.17
$1.17 52-Week Range $12.53

How does INAB compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

INAB AAPG ABEO ABOS ABP

INAB valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.3
48% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

INAB profitability vs Biotechnology peers

ROE
-145.5%
116% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-107.4%
130% below peers (-46.7%)
vs Peers
vs Industry
Weak

INAB financial health vs Biotechnology peers

D/E ratio
3.1
0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
6.9
56% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
0.1
93% below peers (1.0)
vs Peers
vs Industry
More volatile

INAB fundamentals radar

INAB Peer median Industry

INAB profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

INAB vs peers: key metrics